Dr. Alvaro Julian Ramos-Rodriguez, MD

Dr. Ramos-Rodriguez practices at Puerto Rico Pathology Associates P in Bayamon, Puerto Rico.

Dr. Ramos-Rodriguez's NPI, 1346603776, was assigned on April 2, 2016. Dr. Ramos-Rodriguez holds Puerto Rico license 21193.

Dr. Ramos-Rodriguez's primary practice is Puerto Rico Pathology Associates P, at DB-21 Lomas, Bayamon, PR 00961 in Bayamon County. The practice phone is (787) 726-5486.

Dr. Ramos-Rodriguez's primary practice is Puerto Rico Pathology Associates P in Bayamon, Puerto Rico. The medical group on file is Puerto Rico Pathology. Dmand AI also links Dr. Ramos-Rodriguez to 1 more physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ramos-Rodriguez practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatopathology is Dr. Ramos-Rodriguez's primary specialty in the NPI Registry, under taxonomy code 207ND0900X. Dr. Ramos-Rodriguez is licensed in Puerto Rico.

CMS data shows 256 Medicare services from Dr. Ramos-Rodriguez across 5 procedure codes in 2024, for 76 Medicare patients. Medicare paid $16,403 for them. Every service was in an office.

CMS counts 76 Medicare patients who saw Dr. Ramos-Rodriguez in 2024. The largest group is 65 to 74, with 36 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.00, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ramos-Rodriguez's median patient age at 61, with 67% women.

In 2024, Dr. Ramos-Rodriguez wrote 3,968 Medicare Part D claims for 1,050 patients. 95% of them were for generic drugs. CMS names the drug for 3,854 of them, across 23 drugs with 11 or more claims each, at $117,633 in total drug cost. In 2023, CMS named 263 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Ramos-Rodriguez for performance year 2024, reported as part of a group. Dr. Ramos-Rodriguez accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 359 procedures of skin biopsy by Dr. Ramos-Rodriguez, more than 92% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 10 papers to Dr. Ramos-Rodriguez, published from 2018 to 2024. 2018 was the busiest year, with 3. The most frequent topics are Skin Neoplasms, Melanoma and Cyclin-Dependent Kinase Inhibitor p16. Dr. Ramos-Rodriguez has published most often in Int J Dermatol. Dr. Ramos-Rodriguez's most frequent co-authors are Shahrukh K. Hashmi, MD, Julia S. Lehman, MD and Somaira Nowsheen, MD, PhD.

CMS Open Payments shows 142 general payments to Dr. Ramos-Rodriguez from 12 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 90% of the total. Abbvie Inc. paid the most, $1,637.